A study in monkeys comparing the Moderna Inc COVID-19 booster against a shot specifically targeted at the Omicron variant of SARS-CoV-2 showed no significant differences in protection, suggesting that the latter might not be needed, US government researchers reported on Friday. The study involved monkeys vaccinated with two doses of Moderna’s vaccine that were dosed nine months later with either the conventional Moderna booster or one specifically targeting the Omicron variant. The researchers tested various aspects of the animals’ immune responses and exposed them to the virus. They found...